Biological monitoring of nurses exposed to doxorubicin and epirubicin by a validated liquid chromatography/fluorescence detection method

Annals of Occupational Hygiene

Volumn 54, Issue 4, 2010, Pages 368-376

  Pieri, Maria ^a,b   Castiglia, Loredana ^b   Basilicata, Pascale ^a   Sannolo, Nicola ^b   Acampora, Antonio ^a   Miraglia, Nadia ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Doxorubicin; Epirubicin; HPLC FL method validation; Nurses biological monitoring

Indexed keywords

ANALYTICAL METHOD; ANTHRACYCLINES; ANTINEOPLASTIC DRUGS; BIOLOGICAL MONITORING; DATA ACCURACY; DETECTION LIMITS; DETECTION METHODS; DOXORUBICIN; EPIRUBICIN; FLUORESCENCE DETECTION; FOOD AND DRUG ADMINISTRATION; HYGIENIC STANDARDS; METHOD VALIDATIONS; OCCUPATIONAL EXPOSURE; POTENTIAL HEALTH; QUESTIONNAIRE INFORMATION; REPRODUCIBILITIES; SAFETY PRECAUTIONS; SOUTHERN ITALY; URINE SAMPLE; WORK ENVIRONMENTS; WORK ORGANIZATION; WORK SHIFTS; WORKPLACE PRACTICES;

HEALTH RISKS; HOSPITALS; HUMAN ENGINEERING; LAMINAR FLOW; LIQUID CHROMATOGRAPHY; LIQUIDS; NURSING; SOAPS (DETERGENTS);

OCCUPATIONAL RISKS;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; EPIRUBICIN;

ARTICLE; CALIBRATION; CANCER CENTER; ENVIRONMENTAL MONITORING; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ITALY; LABORATORY DIAGNOSIS; METHODOLOGY; NURSING STAFF; OCCUPATIONAL EXPOSURE; ONCOLOGY NURSING; PROTECTIVE CLOTHING; STANDARD; STATISTICS; URINE; UTILIZATION REVIEW; VALIDATION STUDY; WASTE MANAGEMENT;

ANTIBIOTICS, ANTINEOPLASTIC; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DECONTAMINATION; DOXORUBICIN; ENVIRONMENTAL MONITORING; EPIRUBICIN; FLUORESCENCE; HUMANS; ITALY; NURSING STAFF, HOSPITAL; OCCUPATIONAL EXPOSURE; ONCOLOGIC NURSING; ONCOLOGY SERVICE, HOSPITAL; PROTECTIVE CLOTHING; SPECIMEN HANDLING;

EID: 77953004290     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/meq006     Document Type: Article

References (24)

1. Arcamone F. (1984) Antitumor anthracyclines: recent developments. Med Res Rev; 4: 153-188
2. Barbieri A, Nucci MC, Sabatini L et al. (2005) [Occupational exposure to antineoplastic drugs in a hospital setting: biological and environmental monitoring]. Epidemiol Prev; 29: 87-90.
3. Biganzoli L, Cufer T, Bruning P et al. (2003) Doxorubicinpaclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial. Cancer; 97: 40-45
4. Cassinelli G, Configliacchi E, Penco S et al. (1984) Separation, characterization, and analysis of epirubicin (49-epidoxorubicin) and its metabolites from human urine. Drug Metab Dispos; 12: 506-510
5. Chin DL, Lum BL, Sikic BI. (2002) Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci; 779: 259-269
6. Di Francesco R, Griggs JJ, Donnelly J et al. (2007) Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci; 852: 545-553 (Pubitemid 46830986)
7. Errante D, Gabarre J, Ridolfo AL et al. (1999) Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol; 10: 189-195
8. Food and Drug Administration. (2001) Guidance for industrybioanalytical method validation. Center for Drug Evaluation and Research.
9. Friedberg JW, Neuberg D, Kim H et al. (2003) Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity. Cancer; 98: 978-982
10. Fuchs J, Hengstler JG, Jung D et al. (1995) DNA damage in nurses handling antineoplastic agents.Mutat Res; 342: 17-23.
11. Hortobagyi GN. (1997) Anthracyclines in the treatment of cancer. An overview. Drugs; 54 (Suppl 4): 1-7.
12. IARC. (1987) Overall evaluations of carcinogenicity. In Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Lyon, France: IARC. pp. 440.
13. Kosugi S, Kanda T, Nakagawa S et al. (2005) Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma. Scand J Gastroenterol; 40: 886-892
14. Loadman PM, Calabrese CR. (2001) Separation methods for anthraquinone related anti-cancer drugs. J Chromatogr B Biomed Sci Appl; 764: 193-206.
15. Merk-Index. (1976) The Merk Index. Rahway, NJ: Merk & Co.
16. Mikan A, Martinez Lanao J, Gonzalez Lopez F et al. (1990) High performance liquid chromatography determination of doxorubicin and daunorubicin in plasma using UV detection and column switching. Biomed Chromatogr; 4: 154-156
17. Mugitani A, Tatsumi Y, Tanaka K et al. (1999) Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas. Anticancer Res; 19: 3393-3397
18. Painter RB. (1978) Inhibition of DNA replicon initiation by 4-nitroquinoline 1-oxide, adriamycin, and ethyleneimine. Cancer Res; 38: 4445-4449
19. Pethran A, Schierl R, Hauff K et al. (2003) Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health; 76: 5-10.
20. Rekhadevi PV, Sailaja N, Chandrasekhar M et al. (2007) Genotoxicity assessment in oncology nurses handling antineoplastic drugs. Mutagenesis; 22: 395-401.
21. Sottani C, Rinaldi P, Leoni E et al. (2008) Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using highperformance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation. Rapid Commun Mass Spectrom; 22: 2645-2659
22. Sottani C, Tranfo G, Bettinelli M et al. (2004) Trace determination of anthracyclines in urine: a new high-performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel. Rapid Commun Mass Spectrom; 18: 2426-2436
23. Turci R, Sottani C, Ronchi A et al. (2002) Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett; 134: 57-64.
24. Zagotto G, Gatto B, Moro S et al. (2001) Anthracyclines: recent developments in their separation and quantitation. J Chromatogr B Biomed Sci Appl; 764: 161-171